Original Literature | Model OverView |
---|---|
Publication
Title
Lipopolysaccharide signaling in endothelial cells.
Affiliation
Department of Medical Biophysics, British Columbia Cancer Agency, Vancouver,British Columbia, Canada.
Abstract
Sepsis is the systemic immune response to severe bacterial infection. The innateimmune recognition of bacterial and viral products is mediated by a family oftransmembrane receptors known as Toll-like receptors (TLRs). In endothelialcells, exposure to lipopolysaccharide (LPS), a major cell wall constituent ofGram-negative bacteria, results in endothelial activation through a receptorcomplex consisting of TLR4, CD14 and MD2. Recruitment of the adaptor proteinmyeloid differentiation factor (MyD88) initiates an MyD88-dependent pathway thatculminates in the early activation of nuclear factor-kappaB (NF-kappaB) and themitogen-activated protein kinases. In parallel, a MyD88-independent pathwayresults in a late-phase activation of NF-kappaB. The outcome is the productionof various proinflammatory mediators and ultimately cellular injury, leading tothe various vascular sequelae of sepsis. This review will focus on the signalingpathways initiated by LPS binding to the TLR4 receptor in endothelial cells andthe coordinated regulation of this pathway.
PMID
16357866
|
Entity
Process
p38
--
MO000000022
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m34
10
infinite
0
TRANSPATH | MO000000022 |
--
IKK-alpha: IKK-beta: IKK-gamma {phosphorylated}
--
MO000000210
cso30:c:Complex
cso30:i:CC_CellComponent
--
csml-variable:Double
m181
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IkappaB: NF-kappaB
--
MO000000215
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m186
10
infinite
0
TRANSPATH | MO000000215 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRAK-M
--
MO000016569
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1571
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016569 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
A20
--
MO000016591
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1585
10
infinite
0
InterPro | IPR002653 |
TRANSPATH | MO000016591 |
--
LPS
--
MO000016882
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
FADD
--
MO000016899
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1814
10
infinite
0
InterPro | IPR001875 |
TRANSPATH | MO000016899 |
--
Caspase-8
--
MO000016900
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1815
10
infinite
0
TRANSPATH | MO000016900 |
--
PtdIns(3,4)P2
--
MO000017113
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m157532
10
infinite
0
TRANSPATH | MO000017113 |
--
TLR4
--
MO000019394
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3961
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019394 |
--
TRIAD3
--
MO000061958
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m36851
10
infinite
0
TRANSPATH | MO000061958 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
TLR4: MD-2
--
e11
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
LPS: TLR4: MD-2
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m12
0
infinite
0
--
CXCR4: Hsp70: Hsp90: GDF5
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m13
0
infinite
0
--
LPS: CXCR4: Hsp70: Hsp90: GDF5
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m14
0
infinite
0
--
csml-variable:Double
m15
0
infinite
0
--
SHIP1
--
e16
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m68
10
infinite
0
InterPro | IPR000300 |
TRANSPATH | MO000017112 |
--
LPS: TLR4: MD-2: MyD88: TIRAP
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
LPS: TLR4: MD-2: MyD88: TIRAP: IRAK1: IRAK4:TRAF6
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0
infinite
0
--
LPS: TLR4: MD-2: MyD88: TIRAP: IRAK1{p}: IRAK4:TRAF6
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
LPS: TLR4: MD-2: TRAM: TRIF
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m20
0
infinite
0
--
LPS: TLR4: MD-2: TRAM: TRIF: TBK1: IKK-i
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m21
0
infinite
0
--
IRAK1{p}: TRAF6
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
IRAK1{p}: TRAF6: TAK1: TAB1: TAB2: TAB3
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
Uev1A
--
e24
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
IRAK1{p}: TRAF6: TAK1{ activated}: TAB1: TAB1: TAB3: Ubc13: Uev1a
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
csml-variable:Double
m26
0
infinite
0
--
IRAK1 { degraded }
--
e27
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m27
0
infinite
0
--
TRAF6 {ubiquitinated}
--
e28
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
IkappaB {p}: NF-kappaB
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IkappaB {degraded}
--
e30
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
IKK-alpha: IKK-beta: IKK-gamma
--
e31
cso30:c:Complex
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m31
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
NF-kappaB
--
e32
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m32
10
infinite
0
Affymetrix | 1377_at |
Ensembl | ENSG00000109320 |
HGNC | NFKB1 |
OMIM | 164011 |
Proteome | HumanPSD/NFKB1 |
RefSeq | NM_003998 |
TRANSFAC | T01925 |
TRANSPATH | MO000019359 |
Unigene | Hs.654408 |
UniProt | P19838 |
--
NFkappaB {nucleus}
--
e33
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m33
0
infinite
0
--
p38 {activated}
--
e34
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m35
10
infinite
0
TRANSPATH | MO000000022 |
--
ERK {activated}
--
e35
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m37
10
infinite
0
TRANSPATH | MO000000011 |
--
JNK {activated}
--
e36
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m39
10
infinite
0
TRANSPATH | MO000000023 |
--
csml-variable:Double
m40
0
infinite
0
--
NF-kappaB {activated}
--
e38
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m41
10
infinite
0
Affymetrix | 1377_at |
Ensembl | ENSG00000109320 |
HGNC | NFKB1 |
OMIM | 164011 |
Proteome | HumanPSD/NFKB1 |
RefSeq | NM_003998 |
TRANSFAC | T01925 |
TRANSPATH | MO000019359 |
Unigene | Hs.654408 |
UniProt | P19838 |
--
csml-variable:Double
m43
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IL-12
--
e40
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m44
0
infinite
0
--
PI3K {activated}
--
e41
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m45
10
infinite
0
TRANSPATH | MO000000030 |
--
LPS: TLR4: MD-2: TRAM: TRIF: RIP1: TRAF6
--
e42
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m47
0
infinite
0
--
IRF-3 {activated}
--
e43
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m48
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
2 IRF-3 {p}{nucleus}
--
e44
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
csml-variable:Double
m63
10
infinite
0
Affymetrix | 207738_s_at |
Ensembl | ENSG00000061676 |
HGNC | NCKAP1 |
OMIM | 604891 |
Proteome | HumanPSD/NCKAP1 |
RefSeq | NM_013436 |
TRANSPATH | MO000079843 |
Unigene | Hs.603732 |
UniProt | Q9Y2A7 |
--
LPS: TLR4: MD-2: TRAM: TRIF: TBK1: IKK-i: NAP1
--
e46
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m64
0
infinite
0
--
Dok1
--
e47
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m65
10
infinite
0
Affymetrix | 1552849_at |
Ensembl | ENSG00000115325 |
HGNC | DOK1 |
InterPro | IPR002404 |
OMIM | 602919 |
Proteome | HumanPSD/DOK1 |
RefSeq | NM_001381 |
TRANSPATH | MO000087528 |
Unigene | Hs.103854 |
UniProt | Q99704 |
--
Dok2
--
e48
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
NO
--
e49
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m67
0
infinite
0
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LPS: sCD14
--
e6
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
MyD88: TIRAP: ST2
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
SOCS1
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
TLR4: MD-2: RP105: MD2
--
e66
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m73
0
infinite
0
--
TLR4 {ubiquitinated}
--
e67
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m74
0
infinite
0
--
TLR4 {degraded}
--
e68
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m75
0
infinite
0
--
MyD88s
--
e69
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m76
0
infinite
0
--
csml-variable:Double
m7
10
infinite
0
Affymetrix | 104420_at |
Ensembl | ENSMUSG00000020826 |
MGD | Nos2 |
Proteome | HumanPSD/Nos2 |
RefSeq | NM_010927 |
TRANSFAC | G001073 |
Unigene | Mm.2893 |
--
IRAK1{p}: TRAF6: TAK1{p}: TAB1: TAB2: TAB3
--
e70
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m77
0
infinite
0
--
LPS: TLR4: MD-2: MyD88: TIRAP: IRAK1{p}: IRAK4: TRAF6
--
e71
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m78
0
infinite
0
--
IRAK1{p}: TRAF6: TAK1{p}: TAB1: TAB2: TAB3
--
e72
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
IRAK1{p}: TRAF6: TAK1{ activated}: TAB1: TAB2: TAB3: Ubc13: Uev1a
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m80
0
infinite
0
--
IRAK1{p}: nTRAF6: TAK1{ activated}: TAB1: TAB2: TAB3: Ubc13: Uev1a
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m81
0
infinite
0
--
IkappaB {p} {ub}: NF-kappaB
--
e76
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m83
0
infinite
0
--
csml-variable:Double
m84
0
infinite
0
--
TLR4: PI3K
--
e78
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m85
0
infinite
0
--
csml-variable:Double
m86
0
infinite
0
--
Tollip: IRAK1
--
e8
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m8
0
infinite
0
--
2 IRF-3 {p}
--
e80
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m87
0
infinite
0
--
JIP3: TLR4
--
e81
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m88
0
infinite
0
--
2 IRF-3 {p}{nucleus}: p300: OBP
--
e82
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m90
0
infinite
0
--
csml-variable:Double
m91
10
infinite
0
Affymetrix | 1214_s_at |
Ensembl | ENSG00000171855 |
HGNC | IFNB1 |
InterPro | IPR000471 |
OMIM | 147640 |
Proteome | HumanPSD/IFNB1 |
RefSeq | NM_002176 |
TRANSPATH | MO000032635 |
Unigene | Hs.93177 |
UniProt | P01574 |
--
csml-variable:Double
m92
10
infinite
0
Affymetrix | 1418930_at |
Ensembl | ENSMUSG00000034855 |
MGD | Cxcl10 |
Proteome | HumanPSD/Cxcl10 |
RefSeq | NM_021274 |
TRANSFAC | G001062 |
Unigene | Mm.263514 |
--
csml-variable:Double
m93
10
infinite
0
Affymetrix | 100981_at |
Ensembl | ENSMUSG00000034459 |
MGD | Ifit1 |
Proteome | HumanPSD/Ifit1 |
RefSeq | NM_008331 |
TRANSFAC | G043145 |
Unigene | Mm.439751 |
--
IL-8
--
e86
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m94
0
infinite
0
--
SIGIRR: TLR4
--
e87
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m95
0
infinite
0
--
TRIAD3: TLR4
--
e88
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m96
0
infinite
0
--
IRAKM: TRAF6
--
e89
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m97
0
infinite
0
--
AKT {activated}
--
e9
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16
10
infinite
0
TRANSPATH | MO000000048 |
--
MyD88: IRAK-M
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m98
0
infinite
0
--
MyD88: FADD
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m99
0
infinite
0
--
MyD88: FADD: Caspase-8
--
e92
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m100
0
infinite
0
--
csml-variable:Double
m101
0
infinite
0
--
p44
--
e94
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m102
0
infinite
0
--
p42
--
e95
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m103
0
infinite
0
--
p44 {activated}
--
e96
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m104
0
infinite
0
--
p42 {activated}
--
e97
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m105
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m3985*m155666*0.1
nodelay
--
0
PMID: 16357866, 2402637 LBP is an acute-phase protein, the role of which is to bring LPS to the cell surface by binding to LPS and forming a ternary complex with the LPS receptor molecule, CD14.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c42 : 1
m22*m1573*m6433*m1583*m19389*0.1
nodelay
--
0
PMID: 16357866, 12242293 The complex of IRAK1 and TRAF6 dissociates from the receptor to form a complex at the membrane with transforming growth factor-b (TGFb)-activated kinase 1 (TAK1) and the adaptor molecules, TAK1-binding protein 1 and 2 (TAB1 and TAB2). a third adaptor molecule has been identified, TAB3, which also interacts with TAK1. PMID: 16357866, 10882101, 15836773 TAB2 links TAK1 to TRAF6 and facilitates the ubiquitination of TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c35 : 1
stoichiometry:c197 : 1
m6443*m24*m79*0.1
nodelay
--
0
PMID: 16357866 it forms a complex with the ubiquitin conjugating enzyme Ubc13 and the Ubc-like protei.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c45 : 1
m25*0.1
nodelay
--
0
PMID: 16357866 When TAK1 is activated, IRAK1 is released from the complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m15*0.1
nodelay
--
0
PMID: 16357866, 9261174 When TAK1 is activated, IRAK1 is released from the complex and eventually degraded by the ubiquitin?proteasome system.
p14
p14
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c239 : 1
stoichiometry:c112 : 1
m28*m1585*0.1
nodelay
--
0
PMID: 16357866, 14550571 TRAF6 is recycled through the process of deubiquitination. PMID: 16357866 A20 is dependent on its ability to act as a TRAF6 deubiquitinase.
p15
p15
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m25*m31*0.1
nodelay
--
0
PMID: 16357866, 11460167 TAK1-mediated phosphorylation of the IkB kinase (IKK) complex, composed of two catalytic subunits, IKKa and IKKb, and a regulatory subunit, IKK-gamma, also known as NF-kappaB essential modulator (NEMO).
p16
p16
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c57 : 1
stoichiometry:c56 : 1
m186*m181*0.1
nodelay
--
0
PMID: 16357866 Activation of the IKKs leads to downstream phosphorylation of members of the inhibitor of NF-kappaB (IkB) family.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m29*0.1
nodelay
--
0
PMID: 16357866, 7628694 Activation of the IKKs leads to downstream phosphorylation of members of the inhibitor of NF-kB (IkB) family, resulting in ubiquitin-directed proteasome- mediated degradation of the IkB members, thus permitting the release and nuclear translocation of the transcription factor, NF-kB.
p18
p18
cso30:i:ME_Translocation
cso30:i:CC_NuclearInnerMembrane
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m41*0.1
nodelay
--
0
PMID: 16357866, 7628694 Activation of the IKKs leads to downstream phosphorylation of members of the inhibitor of NF-kappaB (IkappaB) family, resulting in ubiquitin-directed proteasome- mediated degradation of the IkappaB members, thus permitting the release and nuclear translocation of the transcription factor, NF-kappaB.
p19
p19
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c65 : 1
stoichiometry:c162 : 1
stoichiometry:c64 : 1
m34*m25*0.1
nodelay
--
0
PMID: 16357866, 11460167 activation of TAK1 also leads to activation of a family of MAPKs consisting of p38, extracellular signal-regulated kinase (ERK) and c-jun NH2-terminal kinase (JNK). PMID: 16357866 SHIP1 also inhibits LPS-induced MAPK activation and IkB-a degradation.
p2
p2
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
stoichiometry:c7 : 1
m5*m6254*0.1
nodelay
--
0
PMID: 16357866, 2402637 LBP is an acute-phase protein, the role of which is to bring LPS to the cell surface by binding to LPS and forming a ternary complex with the LPS receptor molecule, CD14.
p20
p20
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c68 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
stoichiometry:c166 : 1
stoichiometry:c69 : 1
m25*m36*0.1
nodelay
--
0
PMID: 16357866, 11460167 activation of TAK1 also leads to activation of a family of MAPKs consisting of p38, extracellular signal-regulated kinase (ERK) and c-jun NH2-terminal kinase (JNK). PMID: 16357866, 15699069 Overexpression of Dok1 or Dok2 inhibits LPS-induced ERK activation. PMID: 16357866 SHIP1 also inhibits LPS-induced MAPK activation and IkB-a degradation.
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c70 : 1
stoichiometry:c91 : 1
stoichiometry:c90 : 1
stoichiometry:c167 : 1
stoichiometry:c71 : 1
m25*m38*m1066*m45*0.1
nodelay
--
0
PMID: 16357866, 11460167 activation of TAK1 also leads to activation of a family of MAPKs consisting of p38, extracellular signal-regulated kinase (ERK) and c-jun NH2-terminal kinase (JNK). PMID: 16357866, 14699155 LPS-induced JNK activation involves the participation of the protein tyrosine kinase, Syk, and PI3K. PMID: 16357866 SHIP1 also inhibits LPS-induced MAPK activation and IkB-a degradation.
p22
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c74 : 1
stoichiometry:c161 : 1
stoichiometry:c73 : 1
m34*m40*0.1
nodelay
--
0
PMID: 16357866, 12193732 MEKK3 activates both NF-kB and p38 kinase, but not ERK, by binding to TRAF6 in mouse embryonic fibroblasts (MEFs). PMID: 16357866 SHIP1 also inhibits LPS-induced MAPK activation and IkB-a degradation.
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c111 : 1
stoichiometry:c77 : 1
m1116*m183*0.1
nodelay
--
0
PMID: 16357866, 12193732 MEKK3 activates both NF-kB and p38 kinase, but not ERK, by binding to TRAF6 in mouse embryonic fibroblasts (MEFs).
p24
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c79 : 1
stoichiometry:c24 : 1
stoichiometry:c173 : 1
stoichiometry:c261 : 1
stoichiometry:c78 : 1
m32*m40*0.1
nodelay
--
0
PMID: 16357866, 12193732 MEKK3 activates both NF-kB and p38 kinase, but not ERK, by binding to TRAF6 in mouse embryonic fibroblasts (MEFs). PMID: 16357866, 12659860 Expression of A20 inhibits TLR4-mediated NF-kappaB activation by regulating MEKK-1 kinase activity. PMID: 16357866, 12433373, 12433365 ectopic expression of SOCS1 in a macrophage cell line inhibits LPSinduced NF-kappaB activation. PMID: 16357866 A1 inhibits endothelial activation by inhibiting NF-kB activity.
p25
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c33 : 1
stoichiometry:c175 : 1
stoichiometry:c263 : 1
stoichiometry:c82 : 1
m32*0.1
nodelay
--
0
PMID: 16357866 Activation of the IKKs leads to downstream phosphorylation of members of the inhibitor of NF-kappaB (IkappaB) family, resulting in ubiquitin-directed proteasome- mediated degradation of the IkappaB members, thus permitting the release and nuclear translocation of the transcription factor, NF-kappaB. PMID: 16357866, 12659860 Expression of A20 inhibits TLR4-mediated NF-kappaB activation by regulating MEKK-1 kinase activity. PMID: 16357866, 12433373, 12433365 ectopic expression of SOCS1 in a macrophage cell line inhibits LPSinduced NF-kappaB activation. PMID: 16357866 A1 inhibits endothelial activation by inhibiting NF-kB activity.
p26
p26
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c109 : 1
stoichiometry:c88 : 1
stoichiometry:c85 : 1
m71*m183*m5401*0.1
nodelay
--
0
PMID: 16357866, 15864310 LPSinduced intracellular reactive oxygen species (ROS) mediate the formation of a complex between TRAF6 and ASK1 to facilitate activation of p38.
p27
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c89 : 1
stoichiometry:c165 : 1
stoichiometry:c87 : 1
m34*m43*0.1
nodelay
--
0
PMID: 16357866, 15864310 LPSinduced intracellular reactive oxygen species (ROS) mediate the formation of a complex between TRAF6 and ASK1 to facilitate activation of p38. PMID: 16357866 SHIP1 also inhibits LPS-induced MAPK activation and IkB-a degradation.
p28
p28
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c132 : 1
stoichiometry:c139 : 1
stoichiometry:c140 : 1
stoichiometry:c92 : 1
m33*0.1
nodelay
--
0
PMID: 16357866 The MyD88-dependent pathway is largely responsible for controlling the expression of inflammatory cytokines, such as TNF-alpha, IL-6 and IL-12, through activation of NF-kappaB. PMID: 16357866, 12154357, 12052830 Activation of PI3K also reduces MyD88-dependent production of the proinflammatory molecules IL-12 in dendritic cells and TNFa in monocytes. PMID: 16357866, 15699069 Mice that are deficient in Dok1 and Dok2 show an increase in TNFalpha and NO production in peritoneal and bone-marrow derived macrophages, as compared to wild-type cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c93 : 1
m33*0.1
nodelay
--
0
PMID: 16357866 The MyD88-dependent pathway is largely responsible for controlling the expression of inflammatory cytokines, such as TNF-alpha, IL-6 and IL-12, through activation of NF-kappaB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c180 : 1
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m6*m11*0.1
nodelay
--
0
PMID: 16357866, 11274165 Formation of the complex between LPS and CD14 facilitates the transfer of LPS to the LPS receptor complex composed of TLR4 and MD2. PMID: 16357866, 15852007 The complex of RP105 and MD1 interacts with TLR4/MD2, impairing its ability to bind LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c131 : 1
stoichiometry:c94 : 1
m33*0.1
nodelay
--
0
PMID: 16357866 The MyD88-dependent pathway is largely responsible for controlling the expression of inflammatory cytokines, such as TNF-alpha, IL-6 and IL-12, through activation of NF-kappaB. PMID: 16357866, 12154357, 12052830 Activation of PI3K also reduces MyD88-dependent production of the proinflammatory molecules IL-12 in dendritic cells and TNFa in monocytes.
p31
p31
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m22*m42*0.1
nodelay
--
0
PMID: 16357866 activation of TRAF6 also results in the activation of PI3K and Akt.
p32
p32
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
stoichiometry:c110 : 1
stoichiometry:c104 : 1
m46*m20*m183*0.1
nodelay
--
0
PMID: 16357866 The recruitment of these adaptor molecules to the receptor complex results in binding of TRAF6 and RIP1 to TRIF.
p33
p33
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c107 : 1
stoichiometry:c152 : 1
stoichiometry:c174 : 1
stoichiometry:c262 : 1
stoichiometry:c106 : 1
m32*m47*0.1
nodelay
--
0
PMID: 16357866 The recruitment of these adaptor molecules to the receptor complex results in binding of TRAF6 and RIP1 to TRIF, leading to the late-phase activation of NF-kappaB. PMID: 16357866, 12659860 Expression of A20 inhibits TLR4-mediated NF-kappaB activation by regulating MEKK-1 kinase activity. PMID: 16357866, 12433373, 12433365 ectopic expression of SOCS1 in a macrophage cell line inhibits LPSinduced NF-kappaB activation. PMID: 16357866 A1 inhibits endothelial activation by inhibiting NF-kB activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c28 : 1
m33*0.1
nodelay
--
0
PMID: 16357866, 15814722 The recruitment of these adaptor molecules to the receptor complex results in inding of TRAF6 and RIP1 to TRIF, leading to the late-phase activation of NF-kappaB, which contributes to the induction of IFN-beta.
p35
p35
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c83 : 1
stoichiometry:c101 : 1
stoichiometry:c113 : 1
m20*m3902*m1599*0.1
nodelay
--
0
PMID: 16357866 TRAF family member-associated NF-kappaB activator (TANK) binding kinase 1 (TBK1) and IKKepsilon (also known as IKKi) interact with TRIF.
p36
p36
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c116 : 1
stoichiometry:c115 : 1
m977*m21*0.1
nodelay
--
0
PMID: 16357866, 12692549 TRAF family member-associated NF-kappaB activator (TANK) binding kinase 1 (TBK1) and IKKepsilon (also known as IKKi) interact with TRIF and mediate activation of IRF3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c219 : 1
stoichiometry:c118 : 1
m87*0.1
nodelay
--
0
PMID: 16357866, 11244049 Once inside the nucleus, IRF3 controls IFNbeta transcription by recruiting the coactivators, p300 and CBP.
p38
p38
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
stoichiometry:c121 : 1
stoichiometry:c122 : 1
m49*m4512*m2282*0.1
nodelay
--
0
PMID: 16357866, 11244049 Once inside the nucleus, IRF3 controls IFNbeta transcription by recruiting the coactivators, p300 and CBP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c123 : 1
m90*0.1
nodelay
--
0
PMID: 16357866, 11244049 Once inside the nucleus, IRF3 controls IFNbeta transcription by recruiting the coactivators, p300 and CBP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m13*m155666*0.1
nodelay
--
0
PMID: 16357866, 12072369, 11276205 LPS associates with the heat shock proteins, Hsp70 and Hsp90, chemokine receptor 4 (CXCR4) and growth differentiation factor 5 (GDF5).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c234 : 1
stoichiometry:c233 : 1
m93217*0.1
nodelay
--
0
PMID: 16357866, 12692549 activation of IRF3, leading to the induction of IFNb.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m21*m63*0.1
nodelay
--
0
PMID:16357866, 15611223 NF-kappaB activating kinase associating protein (NAP1) also interacts with TRIF and TBK1 to stimulate IFNbeta production through activation of IRF3.
p42
p42
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c130 : 1
stoichiometry:c129 : 1
m977*m64*0.1
nodelay
--
0
PMID:16357866, 15611223 NF-kappaB activating kinase associating protein (NAP1) also interacts with TRIF and TBK1 to stimulate IFNbeta production through activation of IRF3.
p43
p43
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c137 : 1
stoichiometry:c138 : 1
stoichiometry:c134 : 1
m93309*0.1
nodelay
--
0
PMID: 16357866, 15699069 Mice that are deficient in Dok1 and Dok2 show an increase in TNFalpha and NO production in peritoneal and bone-marrow derived macrophages, as compared to wild-type cells.
p44
p44
cso30:i:ME_ChangeInMaterialConcentration
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c143 : 1
stoichiometry:c141 : 1
1.0*0.1
nodelay
--
0
PMID: 16357866, 15699069 Mice that are deficient in Dok1 and Dok2 show an increase in TNFalpha and NO production in peritoneal and bone-marrow derived macrophages, as compared to wild-type cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c144 : 1
1.0*0.1
nodelay
--
0
PMID: 16357866, 10066820 inhibition of PI3K results in the induction of NOS.
p46
p46
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c148 : 1
stoichiometry:c146 : 1
m93479*0.1
nodelay
--
0
PMID: 16357866, 10066820 inhibition of PI3K results in the induction of NOS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m3973*m15*0.1
nodelay
--
0
PMID: 16357866 In unstimulated cells, Tollip forms a complex with IRAK.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c149 : 1
1.0*0.1
nodelay
--
0
PMID: 16357866, 10788611 PI3K has been shown to inhibit the expression of NOS2 in human astrocytes.
p49
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c163 : 1
stoichiometry:c206 : 1
stoichiometry:c159 : 1
m9*m82*0.1
nodelay
--
0
PMID: 16357866, 15935276, 9838078 PI3Ks are a family of kinases that catalyze the phosphorylation of phosphoinositides. The phosphorylated lipid products, phosphatidylinositol (PtdIns) 3,4-bisphosphate and PtdIns 3,4,5-triphosphate, then act as second messengers to activate downstream events, including activation of Akt. PMID: 16357866 SHIP1 negatively regulates LPS-induced activation of Akt downstream of PI3K.
p5
p5
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c172 : 1
stoichiometry:c189 : 1
stoichiometry:c18 : 1
m12*m1572*m6810*0.1
nodelay
--
0
PMID: 16357866, 12691620 MyD88 is recruited to the TLR4 receptor through interaction with the TIR domain of TLR4. PMID: 16357866, 11544529 Upon LPS stimulation, TIRAP also associates with TLR4 via a TIR?TIR interaction, and is essential for MyD88-dependent signaling. PMID: 16357866, 15004556 The inhibitory effect of ST2 is the result of the interaction between its TIR domain and the TIR domains of MyD88 and TIRAP, thus sequestering these critical adaptors during LPS signaling. PMID: 16357866 IRAK-M plays a negative role in TLR4 signaling by preventing the dissociation of IRAK4 and MyD88 and thus preventing the formation of the IRAK?TRAF6 complex.
p50
p50
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c169 : 1
stoichiometry:c170 : 1
stoichiometry:c171 : 1
m22456*m1572*m6810*0.1
nodelay
--
0
PMID: 16357866 The inhibitory effect of ST2 is the result of the interaction between its TIR domain and the TIR domains of MyD88 and TIRAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c177 : 1
stoichiometry:c178 : 1
stoichiometry:c179 : 1
m72*m6500*m11*0.1
nodelay
--
0
PMID: 16357866, 15852007 The complex of RP105 and MD1 interacts with TLR4/MD2, impairing its ability to bind LPS.
p52
p52
cso30:i:ME_Ubiquitination
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c250 : 1
stoichiometry:c182 : 1
m96*0.1
nodelay
--
0
PMID: 16357866, 15107846 TRIAD3A, which contains structural features reminiscent of an E3 ubiquitinprotein ligase and promotes degradation of the receptor by targeting the receptor for ubiquitination and proteolytic degradation.
p53
p53
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c184 : 1
stoichiometry:c185 : 1
m36851*m74*0.1
nodelay
--
0
PMID: 16357866, 15107846 TRIAD3A, which contains structural features reminiscent of an E3 ubiquitinprotein ligase and promotes degradation of the receptor by targeting the receptor for ubiquitination and proteolytic degradation.
p54
p54
cso30:i:ME_Phosphorylation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
m18*0.1
nodelay
--
0
PMID: 16357866 The binding of IRAK4 to the receptor complex facilitates the transphosphorylation of IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c193 : 1
m81*0.1
nodelay
--
0
PMID: 16357866, 10882101, 15836773 TAB2 links TAK1 to TRAF6 and facilitates the ubiquitination of TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c192 : 1
stoichiometry:c195 : 1
m23*0.1
nodelay
--
0
PMID: 16357866 Although TAK1 phosphorylation occurs at the membrane and is dependent on the formation of the TRAF6?TAK1?TAB1?TAB2?TAB3 complex, it does not become active until the complex translocates to the cytoplasm.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c196 : 1
m77*0.1
nodelay
--
0
PMID; 16357866, 12242293 Although TAK1 phosphorylation occurs at the membrane and is dependent on the formation of the TRAF6?TAK1?TAB1?TAB2?TAB3 complex, it does not become active until the complex translocates to the cytoplasm.
p58
p58
cso30:i:ME_Oligomerization
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c198 : 1
stoichiometry:c194 : 1
m80*m36350*0.1
nodelay
--
0
PMID: 16357866 TIFA promotes the oligomerization of TRAF6 and enhances the autoubiquitinating activity of TRAF6.
p59
p59
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c203 : 1
stoichiometry:c80 : 1
stoichiometry:c201 : 1
stoichiometry:c154 : 1
m83*0.1
nodelay
--
0
PMID: 16357866 ubiquitin-directed proteasome-mediated degradation of the IkB members. PMID: 16357866, 11828002 FADD-/- MEFs stimulated with LPS demonstrate increased IkappaB-beta degradation compared to FADD+/+ cells, indicating that the role of FADD is upstream of IkappaB degradation. PMID: 16357866 SHIP1 also inhibits LPS-induced MAPK activation and IkB-a degradation.
p6
p6
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m18998*m19005*m12*0.1
nodelay
--
0
PMID: 16357866, 14519765 MyD88-independent signaling begins with recruitment of the adaptor molecule, TRAM, to the cytoplasmic domain of TLR4. PMID: 16357866, 14519765, 14556004 TRAM is specific to the TLR4 signaling pathway and was cloned as a TLR4-binding protein in yeast that facilitates the binding of TRIF to the receptor complex by forming heterodimers with TRIF.
p60
p60
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c205 : 1
stoichiometry:c200 : 1
stoichiometry:c204 : 1
m347277*m45*0.1
nodelay
--
0
PMID: 16357866, 15935276, 9838078 PI3Ks are a family of kinases that catalyze the phosphorylation of phosphoinositides. The phosphorylated lipid products, phosphatidylinositol (PtdIns) 3,4-bisphosphate and PtdIns 3,4,5-triphosphate, then act as second messengers to activate downstream events, including activation of Akt.
p61
p61
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c207 : 1
stoichiometry:c209 : 1
stoichiometry:c208 : 1
m157532*m9*0.1
nodelay
--
0
PMID: 16357866, 15935276, 9838078 PI3Ks are a family of kinases that catalyze the phosphorylation of phosphoinositides. The phosphorylated lipid products, phosphatidylinositol (PtdIns) 3,4-bisphosphate and PtdIns 3,4,5-triphosphate, then act as second messengers to activate downstream events, including activation of Akt. PMID: 16357866 SHIP1 negatively regulates LPS-induced activation of Akt downstream of PI3K.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c211 : 1
stoichiometry:c212 : 1
m1572*m45*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c214 : 1
stoichiometry:c213 : 1
stoichiometry:c215 : 1
m45*m3961*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c216 : 1
m48*0.1
nodelay
--
0
PMID: 16357866, 11244049 IRF3 is a member of a family of transcription factors that are involved in the induction of type I IFNs that translocate to the nucleus upon phosphorylation and dimerization.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c217 : 1
stoichiometry:c218 : 1
m86*0.1
nodelay
--
0
PMID: 16357866, 11244049 IRF3 is a member of a family of transcription factors that are involved in the induction of type I IFNs that translocate to the nucleus upon phosphorylation and dimerization.
p66
p66
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c220 : 1
stoichiometry:c225 : 1
stoichiometry:c226 : 1
stoichiometry:c221 : 1
m38*m88*0.1
nodelay
--
0
PMID: 16357866, 12941697 activation of JNK is dependent on interaction of the scaffolding protein JNK-interacting protein 3 (JIP3) with the cytoplasmic domain of TLR4. PMID: 16357866 SHIP1 also inhibits LPS-induced MAPK activation and IkB-a degradation.
p67
p67
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c222 : 1
stoichiometry:c223 : 1
stoichiometry:c224 : 1
m3961*m10459*0.1
nodelay
--
0
PMID: 16357866, 12941697 activation of JNK is dependent on interaction of the scaffolding protein JNK-interacting protein 3 (JIP3) with the cytoplasmic domain of TLR4.
p68
p68
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c227 : 1
stoichiometry:c229 : 1
stoichiometry:c230 : 1
stoichiometry:c231 : 1
stoichiometry:c232 : 1
stoichiometry:c228 : 1
m36*m89*0.1
nodelay
--
0
PMID: 16357866, 11163183, 7937886 Tpl2 (also known as Cot) has been implicated in LPS-induced ERK activation in macrophages. Tpl2 has been shown to coordinate with the Ras pathway to induce activation of ERK in COS-1 monkey kidney cells. PMID: 16357866, 15699069 Overexpression of Dok1 or Dok2 inhibits LPS-induced ERK activation. SHIP1 also inhibits LPS-induced MAPK activation and IkB-a degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c235 : 1
stoichiometry:c237 : 1
m49*0.1
nodelay
--
0
PMID: 16357866, 12356687 the MyD88-independent pathway induces expression of IFN-inducible genes, such as IP10 and glucocorticoid-attenuated response gene 16 (GARG16), through activation of the transcription factor, IFN regulatory factor 3 (IRF3).
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c25 : 1
stoichiometry:c150 : 1
stoichiometry:c187 : 1
stoichiometry:c270 : 1
stoichiometry:c26 : 1
m15*m17*m17258*m183*0.1
nodelay
--
0
PMID: 16357866, 12538665 The binding of IRAK4 to the receptor complex facilitates the transphosphorylation of IRAK1, inducing IRAK1 kinase activity. PMID: 16357866, 12538665 MyD88s inhibits TLR4 signaling by preventing the recruitment of IRAK4 to MyD88 in the receptor complex, thus abolishing phosphorylation and activation of IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c236 : 1
stoichiometry:c238 : 1
m49*0.1
nodelay
--
0
PMID: 16357866, 12356687 the MyD88-independent pathway induces expression of IFN-inducible genes, such as IP10 and glucocorticoid-attenuated response gene 16 (GARG16), through activation of the transcription factor, IFN regulatory factor 3 (IRF3).
p71
p71
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c240 : 1
stoichiometry:c241 : 1
stoichiometry:c257 : 1
m1572*m1814*0.1
nodelay
--
0
PMID: 16357866, 10880445 binding of FADD to the DD of MyD88 and subsequent recruitment of caspase 8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c244 : 1
stoichiometry:c243 : 1
m33*0.1
nodelay
--
0
PMID: 16357866, 15852007 RP105-mediated inhibition of IL-8 production was the result of inhibition of NF-kB activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c245 : 1
stoichiometry:c242 : 1
m94*0.1
nodelay
--
0
PMID: 16357866, 15852007 RP105-mediated inhibition of IL-8 production was the result of inhibition of NF-kB activity.
p74
p74
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c246 : 1
stoichiometry:c247 : 1
stoichiometry:c248 : 1
m3961*m41575*0.1
nodelay
--
0
PMID: 16357866, 15866876 SIGIRR has recently been shown to interact with TLR4 through its TIR domain to attenuate recruitment of downstream signaling molecules.
p75
p75
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c183 : 1
stoichiometry:c249 : 1
m36851*m3961*0.1
nodelay
--
0
PMID: 16357866 TRIAD3 was identified as a RING-finger protein that interacts with the cytoplasmic tail of several TLRs, including TLR4.
p76
p76
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c251 : 1
stoichiometry:c252 : 1
stoichiometry:c253 : 1
m1571*m183*0.1
nodelay
--
0
PMID: 16357866 IRAK-M can interact with both MyD88 and TRAF6.
p77
p77
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c254 : 1
stoichiometry:c255 : 1
stoichiometry:c256 : 1
m1572*m1571*0.1
nodelay
--
0
PMID: 16357866 IRAK-M can interact with both MyD88 and TRAF6.
p78
p78
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c258 : 1
stoichiometry:c259 : 1
stoichiometry:c260 : 1
m99*m1815*0.1
nodelay
--
0
PMID: 16357866, 10880445 binding of FADD to the DD of MyD88 and subsequent recruitment of caspase 8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c264 : 1
stoichiometry:c266 : 1
stoichiometry:c268 : 1
m102*m45*0.1
nodelay
--
0
PMID: 16357866, 15100319 Inhibition of PI3K leads to a reduction in the activation of NF-kB and the MAPKs, p38 and p44/42.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c27 : 1
m183*0.1
nodelay
--
0
PMID: 16357866, 8837778 The autophosphorylation and activation of IRAK1 results in the ability to bind TNF receptor-associated factor-6 (TRAF6).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c265 : 1
stoichiometry:c267 : 1
stoichiometry:c269 : 1
m103*m45*0.1
nodelay
--
0
PMID: 16357866, 15100319 Inhibition of PI3K leads to a reduction in the activation of NF-kB and the MAPKs, p38 and p44/42.
p9
p9
cso30:i:ME_Dissociation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c188 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c151 : 1
m19*0.1
nodelay
--
0
PMID: 16357866 The complex of IRAK1 and TRAF6 dissociates from the receptor. PMID: 16357866 IRAK-M plays a negative role in TLR4 signaling by preventing the dissociation of IRAK4 and MyD88 and thus preventing the formation of the IRAK?TRAF6 complex.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--